Volpara unveiled Volpara Enterprise 2.0 software, which helps breast imaging providers deliver personalized breast screening, at last month’s Radiological Society of North America annual meeting in Chicago. Designed to support large or small enterprises, VolparaEnterprise software enables breast imaging providers to provide objective evidence to demonstrate compliance and quality of care.
Read MoreAt the recent Radiological Society of North America annual meeting, Hologic presented its tomosynthesis technology, including a dedicated prone biopsy system with 2D or 3D imaging. This is the first time the company has made the Affirm prone breast biopsy system—a system that’s upgradeable to allow for 3D imaging-guided breast biopsies—for display since securing FDA clearance this year.
Read More
A new AAMI report lays out a framework for how the medical device industry and the FDA could embrace a new—and shared—way of thinking when it comes to considering the benefits and risks of products already on the market. The goal of the document is to make for a clearer and more efficient way of reaching corrective and removal decisions when a problem emerges with a device that is already being sold and used.
Read More
In the largest-ever study on screening mammography outcomes, researchers found that there is no clear cut-off age to stop breast cancer screening. The research, presented at last week’s annual meeting of the Radiological Society of North America in Chicago, adds support for guidelines that encourage screening decisions based on individual patients and their health.
Read More
Biomedical test equipment specialist Rigel Medical is poised to launch its fastest patient simulator to date. Designed and manufactured in the UK, the PatSim 200 mimics the most common vital signs of patients, such as body temperature, blood pressure, heart rate, and respiration.
Read More